Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
30 June 2016
Header
Header image
News

News

PACT Industry Stakeholders Statement
29 June 2016

On the occasion of the meeting on 29 June 2016, of the MEP Interest Group on Access to Healthcare - Better Access, Better Outcomes - Shared [...] Read more

News

EFPIA Statement on Brexit
30 June 2016

As everyone involved in European healthcare considers the implications of the UK referendum result, EFPIA underscores the importance of ensuring that the patient is at [...] Read more

Videos

Video

Investing in Innovation

Pharmaceutical companies are investing 6x more in R&D than the EU’s 2020 R&D intensity target of 3%.

View video

Video

Powering Growth in Europe

For every Euro of direct value added by the pharmaceutical industry, more than 1.3 additional Euros are generated for the whole European economy.

View video

Video

Driving Employment

Throughout the labour market, 5 European jobs are supported for each role created by the pharmaceutical industry.

View video

Events calendar

Events Calendar

Addressing the changing landscape for EU clinical trials
From 07/09/2016 to 09/09/2016 (Brussels)

With the advent of new European regulations, as well as the introduction of innovative research methods and technologies, the clinical trial landscape is fast evolving. 

EORTC will be hosting two events in September, addressing the topics of new EU regulations and new research methodologies in clinical trials:

Navigating Safely through the Regulatory Triangle: (Clinical Trials – In vitro Diagnostics – Data Protection) is a one-day course, which examines how the various elements of these regulations come together, and their potential impact on clinical research. It is targeted at: regulatory specialists in (bio)pharma; representatives of patient advocacy groups; and any other person with an interest in clinical trial regulations and drug development competitiveness in Europe.

Where: Brussels, Belgium – When: 7 September 2016

Innovation and Biomarkers in Cancer Drug Development (IBCD), a first-of-a-kind joint meeting by EORTC, NCI, EMA, and AACR explores the complexity of new cancer drug and biomarker development requirements. IBCD 2016 will help forge multi-stakeholder approaches to cancer drug development with new cancer biomarkers, with an extensive scientific programme that includes input from regulators, industry, academia, patients and payers.

Where: Brussels, Belgium – When: 8-9 September 2016

Read more

Events Calendar

Life Sciences Baltics 2016
From 14/09/2016 to 15/09/2016 (Vilnius, Lithuania)

Life Sciences Baltics 2016 is the only international forum in the Baltics for world-class biotechnology, pharmaceutical and medical devices experts from all around the world. It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking. Discover enormous potential and passion in the field of life sciences in Lithuania and the Baltics – the gateway to emerging markets.

For more information about the event, click here.

Read more

What we are reading

What we are reading

What Does Brexit Mean For The UK's NHS And Healthcare In Europe?
30 June 2016 (Forbes)

The United Kingdom’s decision to leave the European Union has sent shock waves across the world. The economic fallout is widely expected to result in a recession in the UK along with reduced GDP growth across several European countries. 

Read more

What we are reading

It's time to recognise the benefits of medical data use
30 June 2016 (The Guardian)

Using medical data may help improve public health services and help identify patterns of disease, which could lead to more effective practices for prevention

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail